Molecular Diagnostics

Liquid Biopsy Test Launched for NRAS Mutations
The NRAS gene encodes for the N-Ras protein, which is involved in communicating signals from the exterior of the cell to the cell's interior (called signal transduction). These signals provide instructions for a cell to proliferate or differentiate. More...20 Sep 2017

Blood Test Predicts Immunotherapy Efficacy
A test developed with the US-based genetic testing specialist could be significant because, although potent, it is difficult to predict which patients will respond to immunotherapies, which are setting new care standards in some types of tumors. More...20 Sep 2017





In Other News
New Diagnostic Test Improves Detection of Tuberculosis
Gene Related to Abnormal Brain Development Identified
Gene Mutation Increases Risk of Neurodevelopmental Disorders
Serum Level Measurements Improve Disease Risk Prediction
Early Stage Cancer CTCs Indicators of Poor Prognosis
Antibacterial Resistance Revealed in Women with UTIs
Molecular Blood Test Could Diagnose Ischemic Stroke
Side Effects of BP Drugs Genetically Determined
Blood Test Predicts Prostate Tumor Resistance
Liquid Biopsy Panel Yields Complete Molecular Profile
Novel PCR Test Detects H. Pylori Drug Resistance
Molecular Blood Test Could Identify Alzheimer's
New Assay Facilitates Diagnosis of Rare Infant Disease
Disposable POC Device Introduced for Low-Resource Areas
Test Detects Cancer Mutations from Circulating DNA
Molecular Blood Test Developed for Kidney Cancer
Gene Expression Profiling Validated for Uveal Melanoma
Deep Sequencing of Circulating Tumor DNA Detects Cancers Early
Bone Peptide Measurement Predicts Fracture Risk
DNA Sequencing of MRSA Predicts Patient Survival
New Molecular Test Identifies Colorectal Cancer
CRISPR Technology Identifies Cancer-Causing Genes
Liquid Biopsy Approach Inspired by Swarm Behavior
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.







